Implementation of public health genomics in Pakistan

被引:25
|
作者
Riaz, Moeen [1 ]
Tiller, Jane [1 ]
Ajmal, Muhammad [2 ]
Azam, Maleeha [2 ]
Qamar, Raheel [2 ,3 ]
Lacaze, Paul [1 ]
机构
[1] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Publ Hlth Genom, Melbourne, Vic, Australia
[2] COMSATS Univ Islamabad, Dept Biosci, Translat Genom Lab, Islamabad, Pakistan
[3] Pakistan Acad Sci, Islamabad, Pakistan
关键词
PREIMPLANTATION GENETIC DIAGNOSIS; OF-FUNCTION MUTATIONS; FAMILIES; APOC3; ASSOCIATION; TERMINATION; PREVALENCE; PREGNANCY; ABORTION; PROGRAM;
D O I
10.1038/s41431-019-0428-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There has been considerable recent progress in the implementation of public health genomics policy throughout the developed world. However, in the developing world, genetic services still remain limited, or unavailable to most. Here, we discuss challenges and opportunities related to the implementation of public health genomics in developing countries. We focus on Pakistan, a country with one of the world's highest rates of inter-family marriages and prevalence of inherited genetic conditions. Pakistan still lacks a national newborn screening programme, clinical genetic testing services, or public health genomics framework. The medical infrastructure in Pakistan, characterized by limited publicly-funded health services and a significant burden of infectious disease, may contribute to de-prioritization of genetic health services. In addition, there are a number of societal, cultural and religious factors to consider. Recently a number of large research studies have been conducted in populations of Pakistani descent, mostly in collaboration with major US, UK and European institutions. Some of these have yielded high-impact scientific findings, but have yet to translate into public health outcomes in Pakistan. Before the benefits of genomics can be realized in developing countries, the first initial steps towards strategic prioritization, resourcing, and long-term goal setting are required. We propose some practical recommendations and possible first steps forward.
引用
收藏
页码:1485 / 1492
页数:8
相关论文
共 50 条
  • [21] Public Health Genomics in Cancer
    Van den Bulcke, M.
    Boccia, S.
    de Censi, A.
    Decoster, L.
    Frederici, A.
    Kholmanskikh, O.
    Nowak, F.
    Peeters, M.
    Rolfo, C.
    Schmutzler, R.
    Salgado, R.
    Vermeesch, J.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 26
  • [22] Brazil: Public Health Genomics
    Castilla, E. E.
    Luquetti, D. V.
    PUBLIC HEALTH GENOMICS, 2009, 12 (01) : 53 - 58
  • [23] Public Health Genomics: The Essentials
    Burton, Hilary
    JOURNAL OF PUBLIC HEALTH, 2010, 32 (02) : 292 - 293
  • [24] Public health and the challenge of genomics
    Kirkman, M
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2005, 29 (02) : 163 - 165
  • [25] Genomics, medicine and public health
    Trbovich, Alexander M.
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2006, 3 (3-4): : 42 - 45
  • [26] TB GENOMICS FOR PUBLIC HEALTH
    Chee, Cynthia B. E.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S44 - S45
  • [27] Applications of genomics in public health
    Lopez Ridaura, Ruy
    SALUD PUBLICA DE MEXICO, 2007, 49 : E60 - E61
  • [28] China: Public Health Genomics
    Zheng, S.
    Song, M.
    Wu, L.
    Yang, S.
    Shen, J.
    Lu, X.
    Du, J.
    Wang, W.
    PUBLIC HEALTH GENOMICS, 2010, 13 (05) : 269 - 275
  • [29] Pathogen Genomics in Public Health
    Armstrong, Gregory L.
    MacCannell, Duncan R.
    Taylor, Jill
    Carleton, Heather A.
    Neuhaus, Elizabeth B.
    Bradbury, Richard S.
    Posey, James E.
    Gwinn, Marta
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (26): : 2569 - 2580
  • [30] Pathogen Genomics in Public Health
    Armstrong, Gregory L.
    MacCannell, Duncan R.
    Taylor, Jill
    Carleton, Heather A.
    Neuhaus, Elizabeth B.
    Bradbury, Richard S.
    Posey, James E.
    Gwinn, Marta
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2020, 75 (05) : 275 - 276